Is it safe to use hydroxyzine as needed for anxiety in a patient taking dronedarone (Multaq), metoprolol, hydrochlorothiazide, and apixaban (Eliquis)?

Hydroxyzine PRN for Anxiety with This Medication Regimen: Use with Extreme Caution or Avoid

Hydroxyzine should be avoided or used with extreme caution in this patient due to significant QT prolongation risk from the combination with dronedarone (Multaq), particularly given the patient is already on metoprolol which may mask symptoms of arrhythmia.

Critical Drug Interaction Concerns

QT Prolongation Risk - The Primary Safety Issue

Both hydroxyzine and dronedarone carry FDA warnings for QT prolongation and risk of Torsade de Pointes (TdP). The FDA label for hydroxyzine explicitly states: "Caution is recommended during the concomitant use of drugs known to prolong the QT interval. These include Class I and III antiarrhythmics" 1. Dronedarone is a Class III antiarrhythmic agent.

The FDA label for Multaq (dronedarone) specifically warns about "Changes in the electrical activity in your heart called QT interval prolongation. QT interval prolongation can increase your chance of getting dangerous abnormal heart rhythms" 2.

Key evidence:

• Case reports document hydroxyzine-induced TdP even at standard doses, particularly in patients with other risk factors 3
• The 2023 Canadian Cardiovascular Society guidelines emphasize that "avoidance of QT-prolonging medications remains imperative" and note that "among patients receiving β-blockers, the primary reasons for breakthrough events are...receipt of a QT-prolonging medication" 4
• The 2014 European Heart Journal guideline classifies drugs with QT prolongation risk and recommends caution with combinations 5

Dronedarone-Metoprolol Interaction

There is a documented pharmacokinetic interaction between dronedarone and metoprolol. Dronedarone inhibits CYP2D6, increasing metoprolol exposure and producing "an additive dronedarone dose-dependent negative inotropic effect" 6. This combination already increases cardiac effects including:

• Increased QS2i (electromechanical systole duration)
• Decreased Vcfmean (cardiac contractility)
• Bradycardia risk

Adding hydroxyzine, which can also cause bradycardia, compounds this risk.

Dronedarone-Apixaban (Eliquis) Interaction

While not directly related to hydroxyzine safety, it's worth noting that dronedarone increases apixaban exposure by 1.33-1.46 fold 7, with potential for increased bleeding risk (1.45-1.95 fold increase in major bleeding) 7. However, real-world data show this combination is used safely with appropriate monitoring 8, 9.

Clinical Decision Algorithm

If hydroxyzine must be used:

1. Pre-treatment assessment:

   • Obtain baseline ECG to measure QTc interval
   • Check electrolytes (potassium, magnesium) - correct any abnormalities before starting
   • Review for additional QT risk factors: heart failure, recent MI, bradycardia

2. Contraindications to hydroxyzine in this patient:

   • QTc >500 ms (absolute contraindication)
   • QTc 470-500 ms (relative contraindication - avoid if possible)
   • Heart rate <50 bpm
   • Uncorrected hypokalemia or hypomagnesemia

3. If proceeding despite risks:

   • Use the lowest effective dose (12.5-25 mg PRN, not the standard 50 mg)
   • Limit frequency (no more than 2-3 times weekly)
   • Repeat ECG within 1-2 weeks of initiation
   • Monitor electrolytes regularly
   • Educate patient on symptoms of arrhythmia (palpitations, dizziness, syncope)

Safer Alternatives for Anxiety

Given the significant interaction risks, consider these alternatives:

Preferred options:

• Benzodiazepines (e.g., lorazepam, clonazepam) - no QT prolongation risk, though FDA hydroxyzine label warns about CNS depression potentiation 1
• Pregabalin - no QT effects 5
• Buspirone - no significant cardiac effects
• SSRIs (with caution) - some have mild QT effects but generally safer than hydroxyzine in this context

Note: Beta-blockers like metoprolol are sometimes used for anxiety, but recent evidence shows insufficient benefit for anxiety disorders 10, and the patient is already on metoprolol for cardiac indications.

Critical Pitfalls to Avoid

1. Don't assume "PRN" use is safer - even single doses of hydroxyzine can precipitate TdP in high-risk patients 3
2. Don't forget to check the patient's baseline QTc - this is non-negotiable before adding hydroxyzine to dronedarone
3. Don't overlook electrolyte monitoring - hypokalemia/hypomagnesemia dramatically increases TdP risk, especially with HCTZ (which can cause both) 1, 2
4. Don't ignore the cumulative cardiac effects - dronedarone + metoprolol already have additive negative inotropic effects 6

Bottom Line

The combination of hydroxyzine with dronedarone creates a high-risk scenario for life-threatening arrhythmias. The FDA labels for both drugs warn against this combination 1, 2, and guidelines emphasize strict avoidance of QT-prolonging drugs in patients on antiarrhythmics 4. Alternative anxiolytics without QT effects should be strongly preferred. If hydroxyzine is absolutely necessary, use minimal doses with intensive cardiac monitoring including baseline and follow-up ECGs and electrolyte checks.